These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28554008)

  • 1. A bioorthogonal nanosystem for imaging and in vivo tumor inhibition.
    Li B; Liu P; Wu H; Xie X; Chen Z; Zeng F; Wu S
    Biomaterials; 2017 Sep; 138():57-68. PubMed ID: 28554008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrazine-Mediated Bioorthogonal System for Prodrug Activation, Photothermal Therapy, and Optoacoustic Imaging.
    Xie X; Li B; Wang J; Zhan C; Huang Y; Zeng F; Wu S
    ACS Appl Mater Interfaces; 2019 Nov; 11(45):41875-41888. PubMed ID: 31638763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-Cell Dual Drug Synthesis by Cancer-Targeting Palladium Catalysts.
    Clavadetscher J; Indrigo E; Chankeshwara SV; Lilienkampf A; Bradley M
    Angew Chem Int Ed Engl; 2017 Jun; 56(24):6864-6868. PubMed ID: 28485835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A General Strategy for Macrotheranostic Prodrug Activation: Synergy between the Acidic Tumor Microenvironment and Bioorthogonal Chemistry.
    Dong Y; Tu Y; Wang K; Xu C; Yuan Y; Wang J
    Angew Chem Int Ed Engl; 2020 Apr; 59(18):7168-7172. PubMed ID: 32003112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual stimulus-triggered bioorthogonal nanosystem for spatiotemporally controlled prodrug activation and near-infrared fluorescence imaging.
    Zhao Z; Zong Q; Li J; Jiang M; Wang K; Yuan Y
    Chem Commun (Camb); 2023 Mar; 59(26):3878-3881. PubMed ID: 36916644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug.
    Maiti S; Park N; Han JH; Jeon HM; Lee JH; Bhuniya S; Kang C; Kim JS
    J Am Chem Soc; 2013 Mar; 135(11):4567-72. PubMed ID: 23461361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "One-stitch" bioorthogonal prodrug activation based on cross-linked lipoic acid nanocapsules.
    Wang L; Jing P; Tan J; Liao C; Chen Y; Yu Y; Zhang S
    Biomaterials; 2021 Jun; 273():120823. PubMed ID: 33930738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.
    Devkota L; Lin CM; Strecker TE; Wang Y; Tidmore JK; Chen Z; Guddneppanavar R; Jelinek CJ; Lopez R; Liu L; Hamel E; Mason RP; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2016 Mar; 24(5):938-956. PubMed ID: 26852340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-sized metabolic precursors for heterogeneous tumor-targeting strategy using bioorthogonal click chemistry in vivo.
    Lee S; Jung S; Koo H; Na JH; Yoon HY; Shim MK; Park J; Kim JH; Lee S; Pomper MG; Kwon IC; Ahn CH; Kim K
    Biomaterials; 2017 Dec; 148():1-15. PubMed ID: 28957709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
    Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
    J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
    Li Y; Deng Y; Tian X; Ke H; Guo M; Zhu A; Yang T; Guo Z; Ge Z; Yang X; Chen H
    ACS Nano; 2015 Oct; 9(10):9626-37. PubMed ID: 26365698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational Utilization of Black Phosphorus Nanosheets to Enhance Palladium-Mediated Bioorthogonal Catalytic Activity for Activation of Therapeutics.
    Rong M; Liu J; Sun Z; Li T; Li Y; Jiang C; Lu L
    Angew Chem Int Ed Engl; 2023 May; 62(19):e202216822. PubMed ID: 36917027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palladium-mediated dealkylation of N-propargyl-floxuridine as a bioorthogonal oxygen-independent prodrug strategy.
    Weiss JT; Carragher NO; Unciti-Broceta A
    Sci Rep; 2015 Mar; 5():9329. PubMed ID: 25788464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids.
    Jensen SS; Andresen TL; Davidsen J; Høyrup P; Shnyder SD; Bibby MC; Gill JH; Jørgensen K
    Mol Cancer Ther; 2004 Nov; 3(11):1451-8. PubMed ID: 15542784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photo-triggered fluorescent theranostic prodrugs as DNA alkylating agents for mechlorethamine release and spatiotemporal monitoring.
    Cao Y; Pan R; Xuan W; Wei Y; Liu K; Zhou J; Wang W
    Org Biomol Chem; 2015 Jun; 13(24):6742-8. PubMed ID: 25997534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ratiometric two-photon fluorescent probe for imaging of Pd(2+) ions in living cells and tissues.
    Zhou L; Hu S; Wang H; Sun H; Zhang X
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Sep; 166():25-30. PubMed ID: 27203231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypeptide-Based Theranostics with Tumor-Microenvironment-Activatable Cascade Reaction for Chemo-ferroptosis Combination Therapy.
    Gao Z; He T; Zhang P; Li X; Zhang Y; Lin J; Hao J; Huang P; Cui J
    ACS Appl Mater Interfaces; 2020 May; 12(18):20271-20280. PubMed ID: 32283924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Molecular Recognition Approach To Synthesize Nucleoside Analogue Based Multifunctional Nanoparticles for Targeted Cancer Therapy.
    Wang D; Liu B; Ma Y; Wu C; Mou Q; Deng H; Wang R; Yan D; Zhang C; Zhu X
    J Am Chem Soc; 2017 Oct; 139(40):14021-14024. PubMed ID: 28945366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.